RIVOTRIL

This brand name is authorized in Austria, Australia, Brazil, Canada, Ecuador, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Romania, Turkey, South Africa

Active ingredients

The drug RIVOTRIL contains one active pharmaceutical ingredient (API):

1 Clonazepam UNII 5PE9FDE8GB - CLONAZEPAM

Clonazepam exhibits pharmacological properties which are common to benzodiazepines and include anticonvulsive, sedative, muscle relaxing and anxiolytic effects. Animal data and electroencephalographic investigations in man have shown that clonazepam rapidly suppresses many types of paroxysmal activity including the spike and wave discharge in absence seizures (petit mal), slow spike wave, generalised spike wave, spikes with temporal or other locations as well as irregular spikes and waves. Read about Clonazepam

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RIVOTRIL Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
RIVOTRIL Concentrate for solution for injection / infusion	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AE01	Clonazepam	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AE Benzodiazepine derivatives
Discover more medicines within N03AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11520H, 11559J, 12534Q, 1807D, 1808E, 3478C, 5339B
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 529204801117315, 529204802113313, 529204803136317, 529204804116311, 529204805112318, 529204807115314
Country: CA	Health Products and Food Branch	Identifier(s): 00382825, 00382841
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29363-1-09-10, 29364-1-09-10
Country: EE	Ravimiamet	Identifier(s): 1004544, 1103791, 1764479, 1767281
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 52332, 52333, 52334, 52401
Country: FR	Base de données publique des médicaments	Identifier(s): 61496251, 63523836, 68429141
Country: HK	Department of Health Drug Office	Identifier(s): 57397, 57404
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-208455414, HR-H-410362498
Country: IE	Health Products Regulatory Authority	Identifier(s): 64742
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 339
Country: JP	医薬品医療機器総合機構	Identifier(s): 1139003C1044, 1139003C2040, 1139003F1040, 1139003F2047, 1139003F3043
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003918
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 81988, 82115
Country: NL	Z-Index G-Standaard	Identifier(s): 12145246, 12145254
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 2984, 7102, 7110, 7129
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1851, 1852
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68923001, W68924001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699525094889, 8699525594877, 8699525754868
Country: ZA	Health Products Regulatory Authority	Identifier(s): F/2.5/187, F/2.5/190